Cognizant (CTSH) Tops Q1 EPS by 3c, provides guidance
Tweet
Share
E-mail
Get Alerts CTSH Hot Sheet
Price: $62.31 -3.6%
EPS Growth %: +5.8%
Financial Fact:
Weighted average number of common shares outstanding - Basic: 606.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.8%
Financial Fact:
Weighted average number of common shares outstanding - Basic: 606.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cognizant (NASDAQ: CTSH) reported Q1 EPS of $1.23, $0.03 better than the analyst estimate of $1.20. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.06 billion.
GUIDANCE:
Cognizant sees Q2 2025 revenue of $5.14-5.21 billion, versus the consensus of $5.112 billion.
Cognizant sees FY2025 EPS of $4.98-$5.14, versus the consensus of $4.99. Cognizant sees FY2025 revenue of $20.5-21 billion, versus the consensus of $20.551 billion.
For earnings history and earnings-related data on Cognizant (CTSH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- FDA grants accelerated approval to AstraZeneca's camizestrant combo
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
